SHINE Teams with LifeSci

2017-12-11T10:40:17+00:00

December 11, 2017 – Janesville, WI – SHINE Medical Technologies, Inc. (SHINE), a Wisconsin-based company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, announced today that it has joined forces with investor relations firm, LifeSci Advisors, LLC (“LifeSci”) to anchor its outreach to the broader investment community.  LifeSci is […]

SHINE Teams with LifeSci 2017-12-11T10:40:17+00:00

SHINE Selects Baker Concrete Construction

2017-11-16T12:23:33+00:00

SHINE Medical Technologies, Inc. (SHINE), a Wisconsin-based company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, announced today that it has chosen Baker Concrete Construction, Inc. (Baker) to be the prime contractor for the construction of its medical isotope production facility in Janesville, Wisconsin.  In conjunction, Brad Wucherpfennig, President of Baker, has joined the SHINE board of directors.

SHINE Selects Baker Concrete Construction 2017-11-16T12:23:33+00:00

SHINE Breaks Ground on Building One

2017-08-04T15:21:58+00:00

August 4, 2017

Janesville, WI – SHINE Medical Technologies, Inc. (SHINE), a company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, held a groundbreaking ceremony yesterday to celebrate the start of construction on Building One.

The first building to be built for the SHINE campus, Building One will be one […]

SHINE Breaks Ground on Building One 2017-08-04T15:21:58+00:00

Gregory OD Smith Joins SHINE BOD

2017-08-01T08:31:20+00:00

February 13th, 2017 – Janesville, WI – SHINE Medical Technologies, Inc. (SHINE), a company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, announced today that Gregory Smith will join its Board of Directors. The appointment comes as the company prepares to build its facility in Janesville, Wisconsin, after receiving its construction permit from the U.S. Nuclear Regulatory Commission last year. The SHINE facility will produce molybdenum-99 (moly‑99) and other medical isotopes.

Gregory OD Smith Joins SHINE BOD 2017-08-01T08:31:20+00:00

Grand Opening of new SHINE Global HQ

2017-08-01T08:31:03+00:00

January 16, 2017 - SHINE Medical Technologies, Inc. (SHINE), a company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, held a ribbon cutting ceremony to celebrate the grand opening of the company’s new global headquarters in downtown Janesville, Wisconsin. The ribbon cutting was led by the John Beckord and the Forward Janesville Goodwill Ambassadors.

Grand Opening of new SHINE Global HQ 2017-08-01T08:31:03+00:00

SHINE to Present at Piper Jaffray Healthcare Conference

2017-09-18T13:58:17+00:00

November 17, 2016 - SHINE Medical Technologies, Inc. (SHINE), a Wisconsin-based company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, announced today that the company has been invited to speak at the 28th Annual Piper Jaffray Healthcare Conference in New York.

SHINE to Present at Piper Jaffray Healthcare Conference 2017-09-18T13:58:17+00:00

SHINE to Move HQ to Janesville, Wisconsin

2017-10-16T08:50:08+00:00

September 23, 2016 - SHINE Medical Technologies, Inc. (SHINE), a Wisconsin-based company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, announced plans to move its headquarters from Monona to downtown Janesville, Wisconsin late this year.

SHINE to Move HQ to Janesville, Wisconsin 2017-10-16T08:50:08+00:00

SHINE to Present at Mo-99 Topical Meeting

2017-08-01T08:36:30+00:00

September 6, 2016 - SHINE Medical Technologies, Inc. (SHINE), a Wisconsin-based company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, announced today that the company has been invited to speak at the 2016 Mo-99 Topical Meeting hosted by the Department of Energy’s National Nuclear Security Administration (DOE/NNSA).

SHINE to Present at Mo-99 Topical Meeting 2017-08-01T08:36:30+00:00

George Hansrote Joins SHINE

2017-08-01T08:37:45+00:00

July 13, 2016 - SHINE Medical Technologies announced today that George Hansrote will join the company as Vice President of Project Delivery, to manage the construction of the SHINE radioisotope production facility.

George Hansrote Joins SHINE 2017-08-01T08:37:45+00:00

HTA and SHINE Sign Mo-99 Supply Agreement

2017-09-20T14:06:00+00:00

June 21, 2016 - HTA Co., Ltd. (HTA), the largest Chinese producer and distributor of radio-pharmaceuticals, and SHINE Medical Technologies (SHINE), a U.S. company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, announced today that the companies have entered into a strategic agreement for the supply of molybdenum-99 (moly-99).

HTA and SHINE Sign Mo-99 Supply Agreement 2017-09-20T14:06:00+00:00